Hypointensity in T2-weighted images of the basal ganglia in solvent-exposed patients with multiple sclerosis: Clinical, MRI and CSF characteristics

Neurological Sciences

Volumn 24, Issue 1, 2003, Pages 2-9

  Landtblom, A M ^a   Thuomas, K A ^a   Sjoqvist L ^a   Flodin, U ^a   Nyland, F H ^b   Soderfeldt B ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebrospinal fluid; MRI basal ganglia; Multiple sclerosis; Organic solvents; Proton spectroscopy

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; ORGANIC SOLVENT;

ADULT; BASAL GANGLION; BRAIN METABOLISM; BRAIN SCINTISCANNING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MEDICAL RECORD; METABOLITE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; BASAL GANGLIA; ECHO-PLANAR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OCCUPATIONAL EXPOSURE; SOLVENTS;

EID: 0038446508     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720300014     Document Type: Review

References (35)

1. Pryse-Phillips W (1990) The epidemiology of multiple sclerosis. In: Cook SD (ed). Handbook of multiple sclerosis. Marcel Dekker, Nex York; p 12
2. Doinikow B (1915) Über De- und Regenerationserscheinungen an Axelzylindern bei multiplen Sklerose. Z Gesamte Neurol Psychiatr 27:151
3. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278
4. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999) Cortical lesions in multiple sclerosis. Brain 122:17
5. Flodin U, Söderfeldt B, Noorlind Brage H, Fredriksson M, Axelson O (1988) Multiple sclerosis, solvents and pets - a case-referent study. Arch Neurol 45:620
6. Landtblom AM, Flodin U, Karlsson M, Pålhagen S, Axelson O, Söderfeldt B (1993) Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Environ Health 19:399
7. Reis J, Dietemann JL, Warter JM, Poser CM (2001) A case of multiple sclerosis triggered by organic solvents. Neurol Sci 22:155-158
8. Landtblom AM, Flodin U, Söderfeldt B, Wolfson C, Axelson O (1996) Organic solvents and multiple sclerosis: A synthesis of the current evidence. Epidemiology 7:429
9. Axelson O, Hogstedt C (1994) The health effects of solvents. In: Zenz C, Dickerson OB, Horvath EP Jr (eds) Occupational medicine. Mosby, St. Louis, p 764
10. Hormes JT, Filley CM, Rosenberg NL (1986) Neurologic sequelae of chronic solvent vapor abuse. Neurology 36:698
11. Juntunen J, Taskinen E, Luisto M, Iivanainen M, Nurminen M. (1982) Cerebrospinal fluid cells and proteins in patients occupationally exposed to organic solvents. J Neurol Sci 54:413
12. Spencer PS, Schaumburg HH (eds) (1980) Experimental and clinical neurotoxicology. Williams and Wilkins, Baltimore
13. Lawrence WH, Partyk EK (1981) Chronic dysphagia and trigeminal anaesthesia after trichloroethylene exposure. Annal Intern Med 95:710
14. Cavanagh JB (1985) Mechanisms of organic solvent toxicity: morphological changes. In: Organic solvents and the central nervous system. Report on a Joint WHO/Nordic Council of Ministers Working Group, Copenhagen, p 110
15. Brautbar N, Lin R, Gaines G, Vojdani A (2000) Occupational solvent exposure, autoimmunity and connective tissue disease. Eur J Oncol 5[Suppl 2]:17-20
16. Moen BE, Kyvik KR, Engelsen BA, Riise T (1990) Cerebrospinal fluid proteins and free amino acids in patients with solvent induced chronic toxic encephalopathy and healthy controls. Br J Ind Med 47:277
17. Wikkelsö C, Ekberg K, Lillienberg L (1984) Cerebrospinal fluid proteins and cells in men subjected to long-term exposure to organic solvents. Acta Neurol Scand Suppl 70 [Suppl 100]: 113
18. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J (1987) Reduced signal hyperintensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? Am J Neuroradiol 8:413
19. Goodkin DE, Rudick RA, Ross JS (1994) The use of brain magnetic resonance imaging of the brain in multiple sclerosis. Arch Neurol 51:505
20. Dreisbach J, Rosenberg N, Sejbert C, Latchaw R, Brown M (1990) 1.5 Tesla MR findings in toluene abuse patients. Presented at the Annual Meeting of the Western Neurological Society, Santa Fe, NM, 18-21 October 1990
21. Caldemeyer KS, Pascuzzi RM, Moran CC, Smith RR (1993) Toluene abuse causing reduced MR signal intensity in the brain. AJR Am J Radiol 161:1259
22. Unger E, Alexander A, Fritz T, Rosenberg N, Dreisbach J (1994) Toluene abuse: Physical basis for hypointensity of the basal ganglia on T2 weighted MR images. Radiology 193:473
23. Arnold DL, Riess GT, Matthews PM (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 36:76
24. Matthews PM, Francis G, Antel J, Arnold DL (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41:1251
25. Bernsen H, Verhagen W, de Bijl M, Heerschap A (1992) Magnetic resonance studies on brain dysfunction induced by organic solvents. Acta Neurol Belg 92:207
26. Poser C, Paty D, Scheinberg L (1983) New diagnostic criteria for multiple sclerosis. Ann Neurol 13:227
27. Paty DW, Oger JJ, Kastrukoff LF (1988) MRI in the diagnosis of MS; a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180
28. Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444
29. Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M, Sirabian G, Canal N (1995) Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 132:222
30. Grimaud J, Millar J, Thorpe JW, Moseley IF, McDonald WI, Miller DH (1995) Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 59:306
31. Narayanan S, Fu L, Pioro E (1997) Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Neurology 41:385
32. Kermode AG, Thompson AJ, Tofts P (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113:1477
33. Poser CM (1994) The role of the blood-brain barrier in the pathogenesis of multiple sclerosis. In: Salvati S (ed) A multi-disciplinary approach to myelin diseases II. Plenum, New York, p 221
34. Barregård L, Wikkelsö C, Rosengren LE, Aurell A, Thiringer G, Nilson L (1990) Cerebrospinal fluid proteins in men with chronic encephalopathy after exposure to organic solvents. Scand J Work Environ Health 16:423
35. Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S (1994) Occupation, occupational exposure to chemicals and rheumatological disease. Scand J Rhematol 23:305